儿童静脉注射L-氨酸对FeNO,d-ROM和BH4的变化及其在喘治疗中的假定作用
Naho Yamamoto1, Saki Kasuga1, Daijiro Kabata2
1Department of Pediatrics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Journal of asthma and allergy
|March 25, 2024
概括
给儿童服用阿金会增加氧化 (NO) 和降低氧化应激标志物. 这表明氨酸和生物可能有助于减少呼吸道炎症.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 利丁,四二二丁 (BH4) 的代谢产物,是氧化合成酶 (NOS) 的共酶.
- 在呼吸道炎症中,素,NOS,部分呼出的氧化 (FeNO) 和活性氧物种 (ROS) 之间的关系尚未完全理解.
- 氧化应激在呼吸道炎症中起作用,例如在支气管喘中.
研究的目的:
- 为了研究里丁,NOS,FeNO和ROS之间的关系.
- 为了澄清涉及氧化应激的呼吸道炎症的发病原因.
- 评估阿基尼因在儿童中对这些标记物的作用.
主要方法:
- 一项前性,随机的开放标签研究,涉及15名儿童 (4-14岁).
- 参与者接受了生长激素刺激测试和呼吸功能测试.
- 儿童被分为一个用L-氨酸化物治疗的组和一个对照组. 测量包括二烯反应性氧代谢物 (d-ROMs),血清胺,血清氨基酸和FeNO.
主要成果:
- 在30分钟内,氨酸的使用导致FeNO增加和d-ROMs水平降低.
- 在服用后60分钟观察到血清生物的降低和d-ROMs的增加.
- 这些发现表明,NO生产,丁胺水平和氧化应激之间的动态相互作用.
结论:
- 服用L-氨酸增加了NO和降低了d-ROMs,可能会消耗生物,随后增加d-ROMs.
- 减少活性氧物种与缓解炎症相关.
- 氨酸和生物可能具有抑制炎症的潜力.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
261
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
261
01:19Antiasthma Drugs: Leukotriene Modifiers
291
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
291
01:30Adrenergic Agonists: Therapeutic Uses
770
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
770
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
01:20Asthma: Pathogenesis and Management
394
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394